Advertisement
Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Korean Translation
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, S.-H.
Right arrow Articles by Roh, J.-K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, S.-H.
Right arrow Articles by Roh, J.-K.
Related Collections
Right arrow MRI
Right arrow Intracerebral hemorrhage
NEUROLOGY 2009;72:171-176
© 2009 American Academy of Neurology

Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage

Seung-Hoon Lee, MD, PhD, Wi-Sun Ryu, MD and Jae-Kyu Roh, MD, PhD

From the Department of Neurology (S.-H.L., W.-S.R., J.-K.R.) and Clinical Research Center for Stroke, Clinical Research Institute (S.-H.L.), Seoul National University Hospital, Seoul, Republic of Korea.

Address correspondence and reprint requests to Dr. Jae-Kyu Roh, Department of Neurology, Seoul National University Hospital, 28 Yongon-dong, Jongno-gu, Seoul, 110-744, Republic of Korea rohjk{at}snu.ac.kr

Background: Cerebral microbleeds are known to be indicative of bleeding-prone microangiopathy and may predict incident intracerebral hemorrhage (ICH). In this study, we investigated whether microbleeds are associated with the incidence of warfarin-related ICH.

Methods: Twenty-four patients with ICH while on outpatient treatment with warfarin were selected from a consecutive cohort. Control, warfarin-using subjects with no history of ICH were randomly selected during the same time period (n = 48). We compared demographic factors, vascular risk factors, laboratory findings, and radiologic findings including microbleeds between the groups.

Result: There were more cases of patients with microbleeds in the ICH than control group (79.2% vs 22.9%: p < 0.001), and the number of microbleeds was much higher for the ICH group (9.0 ± 26.8 vs 0.5 ± 1.03: p < 0.001). Moreover, the number of microbleeds was significantly correlated with the presence of warfarin-related ICH (r = 0.299; p < 0.001). Conditional logistic regression analysis showed that increased prothrombin time and the presence of microbleeds were independently related to the incidence of warfarin-related ICH (microbleeds: adjusted OR, 83.12).

Conclusion: This study suggests that underlying microbleeds are independently associated with an incidence of warfarin-related intracerebral hemorrhage. Future research should focus on elucidating the risks and benefits of warfarin medication in patients with microbleeds.

Abbreviations: CI = confidence interval; GRE = gradient-echo; ICH = intracerebral hemorrhage; INR = international normalized ratio; NS = not significant; OR = odds ratio; PT = prothrombin time; WMH = white matter hyperintensity.


*These authors contributed equally.

Supported by grants of the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (A060143, A060171, and A060263).

Disclosure: The authors report no disclosures.

Supplemental data at www.neurology.org

Received April 21, 2008. Accepted in final form October 3, 2008.




This article has been cited by other articles:


Home page
NeurologyHome page
A. Biffi, A. Halpin, A. Towfighi, A. Gilson, K. Busl, N. Rost, E. E. Smith, M. S. Greenberg, J. Rosand, and A. Viswanathan
Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy
Neurology, August 24, 2010; 75(8): 693 - 698.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
J. Benbassat, R. Baumal, and Y. Herishanu
Treatment of acute ischemic stroke in patients with cerebral microbleeds: a decision analysis
QJM, July 14, 2010; (2010) hcq119v1.
[Full Text] [PDF]


Home page
StrokeHome page
C. E. Lovelock, C. Cordonnier, H. Naka, R. Al-Shahi Salman, C. L. M. Sudlow, The Edinburgh Stroke Study Group, T. Sorimachi, D. J. Werring, S. M. Gregoire, T. Imaizumi, et al.
Antithrombotic Drug Use, Cerebral Microbleeds, and Intracerebral Hemorrhage: A Systematic Review of Published and Unpublished Studies
Stroke, June 1, 2010; 41(6): 1222 - 1228.
[Abstract] [Full Text] [PDF]


Home page
PNHome page
C. Cordonnier
Brain microbleeds
Practical Neurology, April 1, 2010; 10(2): 94 - 100.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. M. Gregoire, U. J. Chaudhary, M. M. Brown, T. A. Yousry, C. Kallis, H. R. Jager, and D. J. Werring
The Microbleed Anatomical Rating Scale (MARS): Reliability of a tool to map brain microbleeds
Neurology, November 24, 2009; 73(21): 1759 - 1766.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. N. Orken, G. Kenangil, E. Uysal, and H. Forta
Cerebral Microbleeds in Ischemic Stroke Patients on Warfarin Treatment
Stroke, November 1, 2009; 40(11): 3638 - 3640.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
I. Klein, B. Iung, J. Labreuche, A. Hess, M. Wolff, D. Messika-Zeitoun, P. Lavallee, J.-P. Laissy, C. Leport, X. Duval, et al.
Cerebral Microbleeds Are Frequent in Infective Endocarditis: A Case-Control Study
Stroke, November 1, 2009; 40(11): 3461 - 3465.
[Abstract] [Full Text] [PDF]


Home page
JWatch NeurologyHome page
Cerebral Microbleeds and Warfarin-Related Hemorrhage
Journal Watch Neurology, March 31, 2009; 2009(331): 1 - 1.
[Full Text]



Advertisement